Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...

Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Alcaftadine Ophthalmic Solution.

Alembic has a cumulative total of 216 ANDA approvals (189 final approvals and 27 tentative approvals) from USFDA.

ST, the barometer index, the S&P BSE Sensex, was down 149.88 points or 0.18% to 82,353.04. The Nifty 50 index fell 46.90 points or 0.19% to 25,203.20.

Find here all the updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for October 4, 2024 ...

The robust hiring in September showed that the labor market remained strong. The unemployment rate dropped to 4.1 percent. Pandemic Start-Ups Are Thriving, and Helping to Fuel the Economy A record ...

Blasts Shake Beirut as Israel Targets Hezbollah Leaders, Officials Say Israeli officials said planes bombed a bunker where senior Hezbollah officials were meeting, including the presumed successor ...

External affairs minister S Jaishankar meets with Sajith Premadasa, Sri Lanka's opposition leader, during his visit to Colombo. Jaishankar is the first foreign dignitary to visit since the NPP ...

Kent Precision Foods Group, Inc. of Muscatine, IA, is recalling Sqwincher Electrolyte Beverage Mix powder because of potential foreign material in the product, specifically metal. According to the ...

Maldives president Mohamed Muizzu to visit India from October 6, to hold discussions with PM Modi Maldives President Mohamed Muizzu is set to visit India from October 6-10 for his first bilateral ...

Oct. 1, 2024 — The genetic confirmation of a suspected diagnosis of 'hereditary colorectal cancer' is of great importance for the medical care of affected families. However, many of the variants ...

Oct. 2, 2024 — Despite growing evidence of the importance of student well-being and an abundance of best practices, most institutions have yet to prioritize it as much as they do enrollment ...